Stents - Research and Markets - RSS Feed

Carotid Stents - A Global Market Perspective

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:58 GMT

Reduced procedure time, fewer complications, and shortened duration of patient hospitalization are few factors contributing to the growing utilization of carotid stenting procedures. Advent of advanced technologies for carotid stent systems is expected to lead to higher prices for products, thereby enhancing the revenue generation capacity of the market. The carotid artery stents market is also expected to benefit significantly from the expanded coverage for asymptomatic patients.

These and other market data and trends are presented in "Carotid Stents: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Drug-Eluting Stents - Global Market Opportunities

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:56 GMT

Increasing acceptance of stents as viable treatment option, expanding patient population seeking drug-eluting stents, and higher reimbursement coverage are key factors driving growth of drug-eluting stents. Development of innovative treatment methods and preventive measures for coronary diseases, obesity, and diabetes are few factors influencing the long-term growth prospects of the drug-eluting stents market.

Through registering significant growth in the recent past, incidents of adverse effects such as in-stent thrombosis is expected to significantly restrict future market growth. In-stent thrombosis is a common long-term adverse effect of DES where patients develop clots. Although in-stent thrombosis cases occur rarely, they are highly fatal. On the contrary, bare-metal stents do not pose such threats thereby augmenting its usage in interventional management. The rise in in-stent thrombosis cases paves the way for anti-thrombotic therapies. Moreover, drug-eluting stents faces stiff competition from advanced and safer technologies such as tiny wire mesh tubes.

These and other market data and trends are presented in "Drug-Eluting Stents: Global Market Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Coronary Stents - Global Market Trends

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:54 GMT

Aging population, enhanced availability of sophisticated stents, rising patient affluence and affordability, and growing awareness are factors propelling growth of coronary stents Advances in technology and novel formulations from new market entrants, have significantly contributed to market growth...

The Top 60 Manufacturers Of Coronary Stents Worldwide

press@researchandmarkets.com — Thu, 27 Aug 2009 21:08:50 GMT

The first commercially available stent was created by the Argentinean physician, Julio Palmaz His stent has had a major impact on the management of atherosclerotic arterial disease Specifically, it has revolutionized the management of coronary artery disease Many coronary bypass surgeries that would...

U.S. Market for Drug-Eluting & Bare Metal Stents 2009

press@researchandmarkets.com — Wed, 12 Aug 2009 14:34:45 GMT

In 2008, the U S market for drug eluting stents was valued at $1 95 billion, representing an increase of 1 6% over 2007 Overall average selling prices are predicted to decrease over the forecast period Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal...

U.S. Polymers in Medical Devices Market

press@researchandmarkets.com — Wed, 10 Jun 2009 13:02:13 GMT

The study gives an insight into the major polymers - commodity, engineering and high performance - that are used in the production of medical devices, in the United States A detailed analysis of the applications, production by volume and revenues have been included as part of the report In order to...

European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries) (Executive Summary)

press@researchandmarkets.com — Tue, 09 Jun 2009 16:19:50 GMT

In 2008, there were over 60 million units of dental prosthetic devices sold While the growth rate has declined due to the economic recession in 2008 and is expected to continue declining late into 2009, this number is expected to steadily recover, reaching over 80 million by the end of the forecast...

European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries)

press@researchandmarkets.com — Tue, 09 Jun 2009 16:18:48 GMT

Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries) (Executive Summary)

press@researchandmarkets.com — Tue, 09 Jun 2009 11:46:12 GMT

The B R I C Markets for Endoscopic Devices includes: Brazil, Russia, India and China These markets also include: ENT endoscopes, bronchoscopes, colonoscopes, duodenoscopes, enteroscopes, ultrasound endoscopes, urological endoscopes and GI endoscopes In 2008, Russia was the fastest growing market in...

Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries)

press@researchandmarkets.com — Tue, 09 Jun 2009 11:41:27 GMT

European Markets for Peripheral Vascular Devices 2009 (15 Countries) (Executive Summary)

press@researchandmarkets.com — Tue, 09 Jun 2009 11:28:50 GMT

In 2008, the European market for peripheral vascular devices was valued at €623 million, an increase of 3 4% over 2007 This value represents the market for stents, PTA balloons, embolic protection devices, vena cava filters, stent-grafts, surgical grafts, interventional catheters and guidewires,...

European Markets for Peripheral Vascular Devices 2009 (15 Countries)

press@researchandmarkets.com — Tue, 09 Jun 2009 11:26:35 GMT

Global Neurosurgical Product Markets

press@researchandmarkets.com — Wed, 18 Mar 2009 11:15:58 GMT

Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors Intracranial shunts are often used to treat hydrocephalus Aneurysms and AVMs may be treated using surgical clips or,...

IntraCranial Stents Market - Technology & Market Forecast

press@researchandmarkets.com — Fri, 20 Feb 2009 11:18:49 GMT

Intracranial Stenting, using a small incision in the groin to thread a catheter through the arterial highway and place a stent in a cerebral artery, has come of age The technique is increasingly used in stent assisted coil insertion for wide-necked cerebral aneurysms as well as a revascularization...

Drug Eluting Stents Market - Current Situation & Future Forecast

press@researchandmarkets.com — Fri, 20 Feb 2009 11:02:12 GMT

The Market for Drug Eluting Coronary Stents grew by 3% in 2008 reaching $4 2 billion globally Decline in average selling price was offset by growth in procedure volume and improved penetration levels The US market remained stable at $1 8 billion accounting for 43% of the world market The launch of...

Global Vascular Closure Device Markets: U.S., Europe, Rest of World

press@researchandmarkets.com — Wed, 15 Oct 2008 13:04:32 GMT

As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearly $1 billion by 2013 The market for vascular closure technologies, which includes implantable devices and external compression products, has traditionally been concentrated in the...

U.S. Cardiovascular Business Digest - AAA Stent Grafts Market

press@researchandmarkets.com — Wed, 15 Oct 2008 09:24:35 GMT

This research provides an insight into various aspects of the AAA stent grafts market covering various market dynamics, competitive analysis and revenue forecasts for the market...

Carotid Stents - Global Strategic Business Report

press@researchandmarkets.com — Thu, 27 Mar 2008 10:40:09 GMT

This report analyzes the worldwide markets for Carotid Stents in Thousand Units and US$ Million The report provides separate comprehensive analytics for the US, Europe and Rest of World Annual forecasts are provided for each region for the period of 2004 through 2012 The report profiles 10 companies...

Drug Eluting Stents – Technology & Market Forecast

press@researchandmarkets.com — Fri, 07 Mar 2008 14:14:50 GMT

After a difficult year seeing global revenue for drug eluting stents declining to US3 9 billion globally from a peak of US$5 1 billion in 2005, the market for drug-coated stents is getting back on track Over publicized negative outcome results from a sub-group of clinical studies triggered a...

European Markets for Peripheral Stents

press@researchandmarkets.com — Mon, 03 Dec 2007 16:51:46 GMT

This Frost & Sullivan research service titled European Peripheral Stents Market provides detailed analysis of markets for peripheral stents in Europe It deals with the challenges faced by the stents industry in Europe, drivers and restraints as well as the geographic trends that are influencing the...

European Markets for Minimally Invasive Surgical Devices

press@researchandmarkets.com — Tue, 28 Aug 2007 16:27:22 GMT

This Frost & Sullivan research service titled European Markets for Minimally Invasive Surgical Devices offers an overview of the advances in minimally invasive surgical technologies Revenues of select product segments, along with an exhaustive analysis of key market drivers, restraints and trends,...

U.S. Coronary Stent Placements and Bypass Surgical Procedures, 1999-2006

press@researchandmarkets.com — Fri, 16 Mar 2007 14:00:47 GMT

This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets.

A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology.

European Coronary Stents Markets

press@researchandmarkets.com — Thu, 16 Nov 2006 14:42:37 GMT

Budgetary Restraints Affect Growth of Drug Eluting Stents

Drug eluting stents (DES) represent one of the most exciting discoveries made in the field of interventional cardiology. Unique design, pharmacological agents and the drug delivery vehicle of these revolutionary medical devices offer significant advantages over bare metal stents (BMS). However, with the average prices of BMS ranging between $400-800, which is almost half that of DES, these stents score over DES in terms of cost. This is a strong influencing factor for governments to choose BMS over DES, despite the many advantages of the latter. Faced with rising healthcare costs, governments are compelled to curtail hospital budgets. Restricted purchasing power of hospitals combined with a lack of reimbursements has limited the use of DES in Europe, with more than 50 per cent of clinical procedures continuing to use BMS. Increased uptake of DES calls for ongoing clinical trials to highlight the benefits of these stents, especially for certain indications. Manufacturers must also strive to reduce prices of DES; this could help drive sales volumes and ensure repeat purchases.

This Frost & Sullivan research service provides an in-depth analysis of the European coronary stents market, evaluating its business potential in seven key regions of Europe. It discusses the major challenges, drivers and restraints affecting the market and provides strategic recommendations to overcome these challenges. The study includes a detailed assessment of the existing competitive structure and the current market shares of key participants.

Need to Produce Stents that Meet Safety Standards

The safety of the stents currently in the market is a key challenge facing manufacturers. With healthcare providers under pressure to improve levels of service and meet patients’ demands, government officials have started imposing strict safety standards for medical devices and periodical safety reviews by governments have become the norm in

Coronary Stents - Global Strategic Business Report

press@researchandmarkets.com — Tue, 15 Aug 2006 14:04:11 GMT

This report analyzes the worldwide markets for Coronary Stents in Millions of US$ and Thousand Units. The major product segments analyzed are Bare Metal Stents, and Drug Eluting Stents. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 53 companies including many key and niche players worldwide such as Angiotech Pharmaceuticals, Boston Scientific Corp., Cordis Corporation (JNJ), Cook Group, Inc., Medtronic, Inc., Medtronic Vascular, Inc., MIVI Technologies Inc., OrbusNeich, Sorin Biomedica Cardio, and Sun Biomedical Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Drug-Eluting Stents - Global Strategic Business Report

press@researchandmarkets.com — Tue, 06 Jun 2006 12:02:51 GMT

This report analyzes the worldwide markets for Drug-Eluting Stents in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2015.

The report profiles 39 companies including many key and niche players worldwide such as Abbott Vascular, Angiotech Pharmaceuticals, Inc., AngioDynamics®, Inc., Boston Scientific, Inc., Boston Scientific Cardiac Rhythm Management, Biocompatibles International PLC, Biosensors International Pte Ltd., Cordis Corporation, Implant Sciences Corporation, Medtronic, Inc., MIV Therapeutics, Inc., and SurModics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on "Enquire before buying"

Vena Cava Filters - Technology & Market Forecast

press@researchandmarkets.com — Wed, 27 Jul 2005 11:44:29 GMT

New and more advanced Retrievable Vena Cava Filters have recently been developed and introduced resulting in renewed growth and change of dynamics in this established market.

The majority of traditional Permanent Vena Cava Filters were placed after failure of anticoagulation to prevent pulmonary

Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast

press@researchandmarkets.com — Wed, 27 Jul 2005 11:27:12 GMT

Peripheral Arterial Disease (PAD) of the Femoropopliteal System is a major cause of morbidity and limb loss accounting for over 300,000 amputations in the developed world every year.

Medical therapy is often ineffective and open surgery has substantial risks. Less invasive endovascular

Carotid Stenting - Technology & Market Forecast

press@researchandmarkets.com — Wed, 27 Jul 2005 10:11:49 GMT

Carotid Angioplasty and Stenting (CAS) has recently emerged as a popular alternative to endarterectomy for the treatment of carotid atherosclerosis. The recent approval, by the FDA, of carotid artery stents has initiated a global market in those devices.

Guidant, Boston Scientific, Abbott,

Trends in PCI - PCI vs. Thrombolysis: The Debate

press@researchandmarkets.com — Fri, 21 Jan 2005 11:18:22 GMT

Introduction

Drug-eluting stents have become the gold standard in PCI procedures; it is up for debate as to whether biodegradable stents become the future gold standard. The debate about PCI vs thrombolysis still continues, however opinion seems to be falling firmly on the side of PCI.

Emerging Technologies in Global Vascular Intervention: Peripheral Stenting

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

Emerging Technologies in Global Vascular Intervention: Peripheral Stenting is one of a series of reports in Datamonitor''s Emerging Technologies in

Devices and Drugs of Tomorrow 2002: Prevention and Treatment of Coronary Restenosis

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

‘Devices and Drugs of Tomorrow 2002: Prevention and Treatment of Coronary Restenosis’ provides an in-depth, critical evaluation of the key device and drug-based products currently in phase I development and beyond for restenosis. The scope of this report

Advances in Coronary Angioplasty: Drug Eluting Stents

press@researchandmarkets.com — Sat, 05 Oct 2002 12:19:00 GMT

The development of drug-eluting stents has emerged since the use of stenting became particularly prevalent, especially in the US. Stents are